Valiant Laboratories IPO Details
Valiant Laboratories IPO opens on September 27, 2023, and closes on October 3, 2023. The IPO has a total issue size of ₹152.46 Crores, with Valiant Laboratories offering shares at a price range of ₹133 to ₹140 per share. The IPO is scheduled to be listed on the NSE SME. Valiant Laboratories IPO Basis of Allotment is on October 5, 2023. Valiant Laboratories IPO Initiation of Refunds is on October 6, 2023. Valiant Laboratories IPO Credit of Shares to Demat is on October 6, 2023. Valiant Laboratories IPO Listing Date is on October 9, 2023.
Valiant Laboratories IPO Date
- Open – September 27, 2023
- Close – October 3, 2023
- Basis of Allotment – October 5, 2023
- Refunds – October 6, 2023
- A credit of Shares to Demat AC – October 6, 2023
- Listing Date – October 9, 2023
Also Read this
- Valiant Laboratories IPO GMP Today
- Valiant Laboratories IPO Allotment Status
- Valiant Laboratories IPO Subscription Status
- Valiant Laboratories IPO Review
- Valiant Laboratories IPO Date, Price
Valiant Laboratories IPO Price
- Face Value: ₹10 per share
- Price Band: ₹133 to ₹140 per share
- Lot Size: 105 Shares
- Total Issue Size: 10,890,000 shares (aggregating up to ₹152.46 Cr)
- Fresh Issue: 10,890,000 shares (aggregating up to ₹152.46 Cr)
- Offer for Sale: –
- Issue Type: Book Built Issue IPO
- Listing At: BSE, NSE
- Shareholding Pre-Issue: 32,560,000
- Shareholding Post-Issue: 43,450,000
Valiant Laboratories IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1365 | ₹191,100 |
| HNI (Min) | 14 | 1470 | ₹205,800 |
Valiant Laboratories IPO Reservation
| QIB Shares Offered | Not more than 50.00% |
| NII (HNI) Shares Offered | Not less than 15.00% |
| Retail Shares Offered | Not less than 35.00% |
| Anchor Investor Shares Offered | – |
| Total Shares Offered | 100% |
Valiant Laboratories IPO Promoter Holding
Shantilal Shivji Vora, Santosh Shantilal Vora, and Dhanvallabh Ventures LLP (DVL) are the company’s promoters.
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 74.94% |
Valiant Laboratories IPO Financial Report
Amount in ₹ Lakhs
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 | 30 June 2023 |
| Assets | 106.3 | 181.81 | 212.76 | |
| Revenue | 183.78 | 293.47 | 338.77 | |
| Profit After Tax | 30.69 | 27.50 | 29.00 | |
| Net Worth | 88.58 | 71.46 | 100.49 | |
| Reserves and Surplus | ||||
| Total Borrowing | 0.35 | 60.68 | 59.40 |
Valiant Laboratories IPO Reason for issue
The company plans to use the funds generated from the offering for the following purposes:
- Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL), to partially finance the capital expenditure needed for establishing a specialty chemical manufacturing facility at Saykha Industrial Area, Bharuch, Gujarat (Proposed Facility).
- Investment in VASPL to support its working capital needs.
- General corporate uses.
Valiant Laboratories IPO Documentation
- Valiant Laboratories IPO Draft Red Herring Prospectus (DRHP)
- Valiant Laboratories IPO Red Herring Prospectus (RHP)
Company Contact Information
Valiant Laboratories Limited
- Address: 104, Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai -400080
- Phone: +91 2249712001
- Email: complianceofficer@valiantlabs.in
- Website: https://valiantlabs.in/
Valiant Laboratories IPO Registrar
- Link Intime India Private Ltd
- Phone: +91-22-4918 6270
- Email: valiantlaboratories.ipo@linkintime.co.in
- Website: https://linkintime.co.in/mipo/ipoallotment.html